Immix Biopharma replaces auditor KMJ Corbin with Crowe LLP after KMJ partners join Crowe

Immix Biopharma, Inc.

Effective July 17, 2024, Immix dismissed KMJ Corbin & Company LLP and appointed Crowe LLP as its independent registered public accounting firm.
Change follows the partners and professional staff of KMJ joining Crowe; no disagreements or reportable events in fiscal 2022 or 2023.
KMJ's audit reports for the two most recent fiscal years were unqualified and contained no adverse or modified opinions.
KMJ provided a letter agreeing with the dismissal statements, filed as Exhibit 16.1 to this Form 8-K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.